These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 18515085)
1. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Dalamaga M; Karmaniolas K; Nikolaidou A; Chamberland J; Hsi A; Dionyssiou-Asteriou A; Mantzoros CS Eur J Cancer; 2008 Aug; 44(12):1744-53. PubMed ID: 18515085 [TBL] [Abstract][Full Text] [Related]
2. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045 [TBL] [Abstract][Full Text] [Related]
3. Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study. Dalamaga M; Nikolaidou A; Karmaniolas K; Hsi A; Chamberland J; Dionyssiou-Asteriou A; Mantzoros CS Oncology; 2007; 73(1-2):26-32. PubMed ID: 18337619 [TBL] [Abstract][Full Text] [Related]
4. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093 [TBL] [Abstract][Full Text] [Related]
5. Adipocytokines and breast cancer risk. Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Chu MC; Cosper P; Orio F; Carmina E; Lobo RA Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017 [TBL] [Abstract][Full Text] [Related]
7. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Vilarrasa N; Vendrell J; Maravall J; Broch M; Estepa A; Megia A; Soler J; Simón I; Richart C; Gómez JM Clin Endocrinol (Oxf); 2005 Sep; 63(3):329-35. PubMed ID: 16117822 [TBL] [Abstract][Full Text] [Related]
8. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698 [TBL] [Abstract][Full Text] [Related]
9. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Zou CC; Liang L; Hong F Indian Pediatr; 2007 Apr; 44(4):275-9. PubMed ID: 17468522 [TBL] [Abstract][Full Text] [Related]
10. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467 [TBL] [Abstract][Full Text] [Related]
12. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men. Gouni-Berthold I; Berthold HK; Chamberland JP; Krone W; Mantzoros CS Clin Endocrinol (Oxf); 2008 Apr; 68(4):536-41. PubMed ID: 17973945 [TBL] [Abstract][Full Text] [Related]
13. Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension. Papadopoulos DP; Makris TK; Perrea D; Papazachou O; Daskalaki M; Sanidas E; Votteas V Blood Press; 2008; 17(1):50-4. PubMed ID: 18568692 [TBL] [Abstract][Full Text] [Related]
14. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease. Akanji AO; Suresh CG; Al-Radwan R; Fatania HR Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192 [TBL] [Abstract][Full Text] [Related]
16. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516 [TBL] [Abstract][Full Text] [Related]
17. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135 [TBL] [Abstract][Full Text] [Related]
18. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity. Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031 [TBL] [Abstract][Full Text] [Related]
19. Relationship between a wide range of alcohol consumptions, components of the insulin-like growth factor system and adiponectin. Dal Maso L; La Vecchia C; Augustin LS; Mantzoros CS; Kendall CW; Franceschi S Eur J Clin Nutr; 2007 Feb; 61(2):221-5. PubMed ID: 16969380 [TBL] [Abstract][Full Text] [Related]
20. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]